How effective is a complete lumbar fusion in a patient with adhesive arachnoiditis and tethered cord syndrome?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 22, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Lumbar Fusion is Generally Ineffective and Potentially Harmful for Adhesive Arachnoiditis with Tethered Cord Syndrome

Complete lumbar fusion should be avoided in patients with adhesive arachnoiditis and tethered cord syndrome, as fusion does not address the underlying pathophysiology and may worsen neurological outcomes by increasing tension on an already compromised spinal cord.

Why Fusion Fails in This Context

The available guidelines address lumbar fusion only for degenerative disc disease without stenosis or spondylolisthesis 1. These guidelines explicitly do not cover adhesive arachnoiditis or tethered cord syndrome—two distinct pathological entities with completely different mechanisms of pain and dysfunction.

The Core Problem

  • Adhesive arachnoiditis causes pain through inflammation, scarring, and disrupted CSF flow around nerve roots 2. The pathology is inflammatory and mechanical at the arachnoid level, not structural instability requiring fusion.

  • Tethered cord syndrome results from excessive tension on the spinal cord itself 3, 4. Adding a rigid fusion construct to a spine with an already tethered cord creates a biomechanical nightmare—the fusion eliminates compensatory motion that may reduce cord tension during movement.

Evidence Against Fusion in These Conditions

The single case report addressing this specific combination 5 describes a patient with tethered cord who underwent thoracolumbar fusion for different pathology (disc herniation, spondylolisthesis, and ossification of ligamentum flavum). Critically, the authors emphasized that success required avoiding stretching the tethered cord and designing individualized protocols to minimize cord tension. This was not a case of treating the tethered cord or arachnoiditis with fusion—it was managing coexisting degenerative disease while working around the tethered cord.

What Actually Works

For Tethered Cord Syndrome

Surgical untethering is the definitive treatment 3, 6. This involves releasing the tethering structure to eliminate chronic tension on the cord. The evidence shows:

  • Pain relief in almost all cases
  • Stabilization or improvement of neurological function
  • Best outcomes with early intervention 3

For Adhesive Arachnoiditis

Treatment options are limited but do not include fusion:

  • Endoscopic subarachnoepidurostomy can restore CSF flow and reduce pain through internal shunting between subarachnoid and epidural spaces 7
  • Pharmacological management for pain control 2
  • In severe cases with CSF circulation disturbances, gravity-controlled valve systems for subarachnoid-peritoneal shunts 7

Critical Pitfalls to Avoid

  1. Do not apply degenerative disease guidelines to inflammatory/congenital pathology: The fusion guidelines 8, 1 show that even in ideal degenerative cases, fusion outcomes correlate poorly with radiographic success and have high complication rates. Applying fusion to non-degenerative pathology lacks any evidence base.

  2. Fusion increases adjacent segment stress: This is particularly dangerous when the cord is already tethered, as it eliminates the spine's ability to distribute mechanical forces 9.

  3. The diagnostic trap: MRI findings in arachnoiditis (adherent nerve roots, empty thecal sac, pseudocysts) are often not correlated with clinical symptoms 2. Don't operate based on imaging alone.

The Treatment Algorithm

Step 1: Confirm both diagnoses with high-resolution MRI showing:

  • Arachnoiditis: clumped nerve roots, empty thecal sac appearance
  • Tethered cord: low-lying conus (below L2-L3), thickened filum terminale

Step 2: If tethered cord is symptomatic (progressive pain, motor deficits, urinary dysfunction):

  • Proceed with surgical untethering first 3, 6
  • This addresses the primary mechanical pathology

Step 3: For arachnoiditis-related pain after untethering or if cord is asymptomatic:

  • Trial pharmacological management
  • Consider endoscopic intervention if CSF flow is compromised 7
  • Reserve shunting for severe cases with documented CSF circulation problems

Step 4: Only consider fusion if there is separate, coexisting degenerative pathology (spondylolisthesis, stenosis) causing distinct mechanical symptoms, and only after addressing the tethered cord 5.

Bottom Line

Lumbar fusion does not treat adhesive arachnoiditis or tethered cord syndrome. It may actually worsen outcomes by adding rigidity to a system already compromised by inflammation and abnormal cord tension. Address the actual pathology: untether the cord if symptomatic, restore CSF flow if blocked, and manage pain appropriately. Fusion is only relevant if there is documented, symptomatic degenerative disease as a separate entity—and even then, outcomes are uncertain given the underlying conditions 10, 11.

Related Questions

Is it normal for a 51-year-old patient with tethered cord syndrome, adhesive arachnoiditis, chronic osteomyelitis, and intractable pain to work 60 hours per week and be completely exhausted on Saturday?
Can patients with tethered cord syndrome experience intermittent urinary incontinence?
What causes worsening low back (L4‑5) and sacral pain in a patient with adhesive arachnoiditis and tethered cord syndrome?
What are the best exercises for numbness caused by lumbar adhesive arachnoiditis?
What type of exercise is most appropriate for a patient with tethered cord syndrome, adhesive arachnoiditis, and chronic osteomyelitis?
Should I monitor vitamin B12 status in a patient taking pantoprazole?
What are the instructions for use of topical Winlevi (clascoterone) cream, Finagel (ciclopirox) nail lacquer, Retin‑A (tretinoin) cream or gel, and Benzaclin (benzoyl peroxide 5% + clindamycin 1%) gel?
What is the recommended intramuscular dose of triamcinolone acetonide for treating an allergic reaction in adults and in children (by weight)?
What are the drug interactions and safety considerations when using Invega Sustenna (paliperidone palmitate) together with risperidone?
A patient has been taking Losartan potassium/hydrochlorothiazide 100‑25 mg twice daily for three years with well‑controlled blood pressure, but this exceeds the recommended maximum daily dose of Losartan 100 mg. How should the medication regimen be adjusted?
What are the risk factors for fibrocystic (fibrocytic) breast disease in adult women, especially those of reproductive age?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.